Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale — India Imports 2023
Country-wise import data for HS 3003
$216.1M
Total Imports (2023)
27
Supplying Countries
China
Top Supplier
Country-Wise Import Data — 2023
| # | Country | Import Value (USD) | Share | Quantity |
|---|---|---|---|---|
| 1 | 🇨🇳 China | $80.7M | 37.3% | 802,506 |
| 2 | 🇩🇪 Germany | $44.7M | 20.7% | 129,188 |
| 3 | 🇨🇦 Canada | $32.1M | 14.9% | 10,015,322.01 |
| 4 | 🇳🇱 Netherlands | $23.2M | 10.7% | 20,839.1 |
| 5 | 🇳🇵 Nepal | $19.5M | 9.0% | 2,812,360 |
| 6 | 🇰🇷 South Korea | $6.1M | 2.8% | 60,804 |
| 7 | 🇲🇽 Mexico | $3.4M | 1.6% | 13,460 |
| 8 | 🇫🇷 France | $2.4M | 1.1% | 67,316 |
| 9 | 🇦🇹 Austria | $1.5M | 0.7% | 87,238 |
| 10 | 🇮🇳 India | $1.1M | 0.5% | 82,543.41 |
| 11 | 🇮🇹 Italy | $444K | 0.2% | 6,694.09 |
| 12 | 🇷🇴 Romania | $311K | 0.1% | 3,772 |
| 13 | 🇺🇸 United States | $211K | 0.1% | 8,275.1 |
| 14 | 🇧🇪 Belgium | $153K | 0.1% | 28.06 |
| 15 | 🇿🇦 South Africa | $21K | 0.0% | 108 |
| 16 | 🇸🇮 Slovenia | $20K | 0.0% | 240 |
| 17 | 🇨🇭 Switzerland | $17K | 0.0% | 10.13 |
| 18 | 🇬🇧 United Kingdom | $11K | 0.0% | 142 |
| 19 | 🇹🇭 Thailand | $9K | 0.0% | 508 |
| 20 | 🇫🇮 Finland | $7K | 0.0% | 579.7 |
| 21 | 🇵🇱 Poland | $6K | 0.0% | 12 |
| 22 | 🇦🇺 Australia | $2K | 0.0% | 156.91 |
| 23 | 🇮🇪 Ireland | $746 | 0.0% | 4.16 |
| 24 | 🇻🇳 Vietnam | $245 | 0.0% | 4 |
| 25 | 🇳🇿 New Zealand | $147 | 0.0% | 2 |
| 26 | 🇮🇩 Indonesia | $20 | 0.0% | — |
| 27 | 🇪🇸 Spain | $20 | 0.0% | 1.94 |
| Total | $216.1M | 100% | ||
← Back to Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale import overviewView export data for Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale →
India's Import Market for Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale
Explore sourcing opportunities and supplier data.
Contact XIMPEX